Search hospitals
>
Florida
>
Miami Beach
Mount Sinai Medical Center
Claim this profile
Miami Beach, Florida 33140
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Prostate Cancer
Conducts research for Pancreatic Cancer
Conducts research for Colorectal Cancer
447 reported clinical trials
19 medical researchers
Summary
Mount Sinai Medical Center is a medical facility located in Miami Beach, Florida. This center is recognized for care of Breast Cancer, Lung Cancer, Prostate Cancer, Pancreatic Cancer, Colorectal Cancer and other specialties. Mount Sinai Medical Center is involved with conducting 447 clinical trials across 519 conditions. There are 19 research doctors associated with this hospital, such as Mike Cusnir, MD, Michael A. Schwartz, Brian Slomovitz, and Oleg Gligich.
Area of expertise
Breast Cancer
Mount Sinai Medical Center has run 86 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Mount Sinai Medical Center has run 80 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Mike Cusnir, MD
Mount Sinai Medical Center
3 years of reported clinical research
Michael A. Schwartz
Mount Sinai Medical Center
9 years of reported clinical research
Brian Slomovitz
Mount Sinai Comprehensive Cancer Center
3 years of reported clinical research
Oleg Gligich
Mount Sinai Medical Center
2 years of reported clinical research
Clinical Trials running at Mount Sinai Medical Center
Bladder Cancer
Breast Cancer
Prostate Cancer
Breast cancer
Lung Cancer
Ovarian Cancer
Kidney Cancer
Bladder Carcinoma
Cancer
Esophageal cancer
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
Blood Sample Collection
for Cancer Detection
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting
1 award
N/A
9 criteria
Blood Test and Immunotherapy
for Bladder Cancer
This phase II/III trial examines whether patients who have undergone surgical removal of bladder, kidney, ureter or urethra, but require an additional treatment called immunotherapy to help prevent their urinary tract (urothelial) cancer from coming back, can be identified by a blood test. Many types of tumors tend to lose cells or release different types of cellular products including their DNA which is referred to as circulating tumor DNA (ctDNA) into the bloodstream before changes can be seen on scans. Health care providers can measure the level of ctDNA in blood or other bodily fluids to determine which patients are at higher risk for disease progression or relapse. In this study, a blood test is used to measure ctDNA and see if there is still cancer somewhere in the body after surgery and if giving a treatment will help eliminate the cancer. Immunotherapy with monoclonal antibodies, such as nivolumab and relatlimab, can help the body's immune system to attack the cancer, and can interfere with the ability of tumor cells to grow and spread. This trial may help doctors determine if ctDNA measurement in blood can better identify patients that need additional treatment, if treatment with nivolumab prolongs patients' life and whether the additional immunotherapy treatment with relatlimab extends time without disease progression or prolongs life of urothelial cancer patients who have undergone surgical removal of their bladder, kidney, ureter or urethra.
Recruiting
1 award
Phase 2 & 3
10 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mount Sinai Medical Center?
Mount Sinai Medical Center is a medical facility located in Miami Beach, Florida. This center is recognized for care of Breast Cancer, Lung Cancer, Prostate Cancer, Pancreatic Cancer, Colorectal Cancer and other specialties. Mount Sinai Medical Center is involved with conducting 447 clinical trials across 519 conditions. There are 19 research doctors associated with this hospital, such as Mike Cusnir, MD, Michael A. Schwartz, Brian Slomovitz, and Oleg Gligich.
Where is Mount Sinai Medical Center located?
**Mount Sinai Medical Center - Miami Beach, FL** - **Address:** 4300 Alton Rd, Miami Beach, FL - **Directions:** Take I-195 E to the Alton Road exit. Head south on Alton Road for approximately one mile. - **Parking:** Visitor parking is available in the parking garage located at the hospital's address.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Mount Sinai Medical Center, patients can contact the Customer Service department at 305-674-2130, available Monday-Friday, 9:00am to 4:00pm. The Resource, Entitlement and Advocacy Program (REAP) assists with government health insurance programs and requires a referral by a Social Worker. The Charity Care Program offers financial aid to eligible patients; for application details, call the Financial Counseling Office at 212-979-4306.
What insurance does Mount Sinai Medical Center accept?
Mount Sinai Medical Center accepts a wide range of insurance plans for urgent care, including but not limited to: - Various Aetna plans (HMO, PPO/POS, Medicare) - Cigna plans (HMO, Indemnity, Open Access, POS, PPO/EPO) - Empire BCBS (PPO/POS/EPO, HMO, Healthy New York, Mediblue, Top Tier) - EmblemHealth (CBP PPO, CompreHealth NY Metro Network-HIP EPO/HMO) - HIP (EPO, Healthy NY Plan, HMO-Classic, Medicare Advantage) - United Healthcare (PPO/POS/EPO, HMO, Empire Plan, Medicare) - Other plans including 1199 National Benefit Fund, Fidelis, Healthfirst, Magnacare, Medicare, Oscar, Oxford plans, and PHCS/Multiplan. For the most current insurance information, please contact Mount Sinai Medical Center directly.
What awards or recognition has Mount Sinai Medical Center received?
Mount Sinai Medical Center in Miami Beach, Florida, is renowned for its high-quality care, underscored by numerous awards and recognitions. This institution has been acknowledged by the Agency for Healthcare Research and Quality (AHRQ) for its exceptional quality data. Its commitment to excellence is further bolstered by a robust focus on teaching and research.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.